ACT 2 Logo
TREATMENT · TADALAFIL · PROSTATE

Tadalafil for an Enlarged Prostate: The Second Approval

Most men know tadalafil as an erectile dysfunction drug. Fewer know that the FDA approved it in 2011 for something else — the lower urinary tract symptoms of benign prostatic hyperplasia — and that the once-daily form is the one that indication uses. It is a separate, labeled indication with its own trials behind it, not an off-label hope.

It matters most to one man in particular: the one getting up twice a night who has also noticed that erections are not what they were. Those problems arrive together far more often than coincidence explains, and almost every other way of treating one tends to worsen the other. This is the exception. Daily tadalafil is one tablet for both.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.

What it does to the prostate — and what it does not

The mechanism is the erectile one applied to different tissue. Tadalafil inhibits PDE5, which raises cyclic GMP, which relaxes smooth muscle — and there is a great deal of smooth muscle in the prostate, the bladder neck and the pelvic vessels. Relaxing it reduces the resistance urine has to push against.

What it does not do is make the prostate smaller. Tadalafil does not shrink prostate tissue, prevent or treat prostate cancer, or lower a PSA result. It relaxes the muscle around the obstruction rather than removing it — a distinction that explains what improves and what does not.

What improvement realistically looks like

Lower urinary tract symptoms are the ordinary indignities: urgency, going more often, getting up at night, a stream that has lost its force, hesitancy, dribbling, the sense that the bladder has not quite emptied. They are scored on a standard questionnaire, and treatment is judged by how far that score falls.

On that measure daily tadalafil produces a real improvement — consistently better than placebo, and in the same general range as the older drugs where they have been compared directly. Men tend to notice within a few weeks.

The honest qualifier: when investigators measure urine flow itself rather than asking how men feel, tadalafil's effect is smaller than an alpha-blocker's, and in several trials it did not separate clearly from placebo on flow even while symptom scores improved. The change is real but moderate — relief, not a restored plumbing system.

Against the alternatives

Alpha-blockers, usually tamsulosin, are what most men are offered first. They work within days rather than weeks and they do more for flow. But they lower blood pressure, and dizziness on standing is the common reason men stop them; they cause retrograde ejaculation in a substantial minority, where ejaculate goes backward into the bladder rather than out; and they are associated with a complication during cataract surgery, so an ophthalmologist needs to know.

5-alpha-reductase inhibitors — finasteride, dutasteride — block the conversion of testosterone to DHT and, over months, genuinely shrink the gland. They are the right choice for a substantially enlarged prostate and the only class shown to reduce the long-term risk of urinary retention and surgery. But they are slow, half a year or more before the benefit is clear; they lower PSA, which changes how future screening is read; and they carry sexual side effects of their own, including reduced libido and erectile difficulty.

So the pattern repeats. Both established options tend to worsen sexual function. Tadalafil is the one that does not.

Who benefits most

The man with both problems. If erections have declined and urinary symptoms have arrived together, one daily tablet treats both and neither alternative can say that — which is also the strongest case for daily over as-needed dosing, covered in daily versus as-needed. The man with urinary symptoms alone has a more even choice, and an alpha-blocker may serve him better. Combining the two is done and appears to add benefit, but it compounds the blood pressure effect and belongs to a clinician who knows the whole medication list.

Two safety points that apply directly here

Nitrates: never. Tadalafil with any nitrate — nitroglycerin in any form, isosorbide mononitrate or dinitrate, or amyl nitrite ("poppers") — can cause a severe and potentially fatal drop in blood pressure. This is an absolute contraindication, not a risk to be weighed against benefit. If you carry nitroglycerin for chest pain, this is not for you.

Alpha-blockers: additive. Both drugs lower blood pressure, and men with prostate symptoms are frequently already on an alpha-blocker. Together they can drop it far enough to cause dizziness or fainting. That can sometimes be managed, but it is a clinical decision, and your prescriber has to know about both.

The usual cautions also apply — recent heart attack or stroke, unstable angina, uncontrolled blood pressure, certain inherited retinal disorders. The hub page lists them in full.

Get the symptoms assessed before you treat them

Urinary symptoms in a man over fifty are not self-diagnosing. The same complaints come from prostate cancer, infection, bladder stones, an overactive or underactive bladder, diabetes, neurological disease, and medications already being taken. Benign prostatic hyperplasia is the most likely explanation, but "most likely" is not a diagnosis, and treating symptoms without knowing their cause can delay the diagnosis that mattered.

Assessment means a history, a symptom score, a urine test, a PSA discussion, an examination, sometimes imaging — some of which needs an in-person visit. Our clinicians will say when that is what you need rather than prescribing around it. Lab testing is where the workable part starts; all lab tests sets out what we can run.

Questions

Frequently asked questions

  • Yes — the FDA approved it in 2011 for the lower urinary tract symptoms of benign prostatic hyperplasia, separately from its erectile dysfunction approval. The daily form is the one that indication uses.

  • No. It relaxes smooth muscle in the prostate, bladder neck and pelvic vessels, which eases the symptoms. The gland itself is unchanged, and it does not lower PSA or treat prostate cancer.

  • An alpha-blocker works faster and does more for flow. Tadalafil improves symptom scores comparably in the trials but does less for flow — and it does not cause dizziness or retrograde ejaculation.

  • Sometimes, under supervision. Both lower blood pressure and the effect is additive, which can mean dizziness or fainting. Your prescriber has to know you are on both.

  • Usually a few weeks rather than a few days. If nothing has changed after a fair trial, report it — see when it does not work.

  • No. Urgency, frequency and a weak stream overlap with prostate cancer, infection and bladder disease. They need assessing before they are treated, and some of that has to happen in person.

Your next step

Where this fits in your plan

If urinary symptoms are part of why you are here, say so in the assessment. It changes the recommendation, and it is the most useful thing you can tell the clinician reviewing your intake.

If erections are the main issue and the urinary symptoms are incidental, the comparison you want is tadalafil versus sildenafil, or the vascular question raised in erectile difficulty as a heart signal. If desire rather than function has changed, that is a testosterone conversation.

We measure first. Then we act.

References

  1. Cialis (tadalafil) prescribing information — Indications and Usage (benign prostatic hyperplasia); Contraindications (nitrates); Warnings and Precautions (alpha-blockers, cardiovascular, ocular).
  2. American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia — AUA Guideline.
  3. European Association of Urology. Guidelines on the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms, including Benign Prostatic Obstruction.
  4. Roehrborn CG et al. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. Journal of Urology 2008.
  5. Gacci M et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. European Urology 2012.
  6. Porst H et al. Effects of tadalafil once daily on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile function in men with both conditions — pooled analyses of randomized placebo-controlled trials. European Urology.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

Urinary symptoms in men over fifty require clinical assessment before treatment, because they overlap with prostate cancer, infection and bladder disease. Do not take tadalafil with any nitrate medication.

We measure first. Then we act.

Start with a baseline. Then decide about tadalafil daily.